Year: 2018
Type: editorial
Abstract: Bladder cancer can be aggressive and develop resistance to currently available cancer therapies. An estimated 81,190 new cases of bladder cancer will be diagnosed in 2018 and 18,810 deaths from bladder cancer will occur in 2018 in the US (1). Both the absolute numbers of cases and deaths from bladder cancer have increased by 45% and 35%, respectively, since 2002 (2,3). Bladder cancer ranks as the 4 th most common cancer in men affecting males 4 times the rate as females and in the top 10 common cause of cancer deaths in men and women in the US (1). In addition, bladder cancer has a high rate of recurrence compared to other tumor types (4), thus it an ideal population for health promotion efforts.
Author: Charles J. Rosser
Institution: Cedars-Sinai Medical Center
Language: English
Topic: Cancer survivorship and care
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W2905672122